Equities

NCAC

KYG6448C1033

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-22 pm EDT			5-day change	1st Jan Change
0.8621 ^USD	+1.57%		+1.21%	-90.67%

Jan. 25	Newcourt Acquisition Corp(NasdaqGM:NCAC) dropped from NASDAQ Composite Index	CI
Jan. 25	Psyence Therapeutics Corp. completed the acquisition of Newcourt Acquisition Corp from Newcourt SPAC Sponsor LLC, Polar Asset Management Partners Inc. and others in a reverse merger transaction.	CI

Newcourt Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022

November 14, 2022 at 04:24 pm EST

Newcourt Acquisition Corp reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net income was USD 0.766838 million compared to net loss of USD 0.045057 million a year ago.
For the nine months, net income was USD 5.76 million.

Latest news about NEWT ACQU

Newcourt Acquisition Corp(NasdaqGM:NCAC) dropped from NASDAQ Composite Index	Jan. 25	CI
Psyence Therapeutics Corp. completed the acquisition of Newcourt Acquisition Corp from Newcourt SPAC Sponsor LLC, Polar Asset Management Partners Inc. and others in a reverse merger transaction.	Jan. 24	CI
Wall Street Set to Open Flat as Investors Eye Key Manufacturing Index	Jan. 23	MT
Top Premarket Decliners	Jan. 23	MT
Newcourt Acquisition Extends Closing Date for Merger; Shares Sink Premarket	Jan. 23	MT
Newcourt Acquisition Extends Closing Date for Merger	Jan. 23	MT
Top Premarket Decliners	Jan. 18	MT
Newcourt Acquisition Corp announced that it expects to receive $10 million in funding from Psyence Therapeutics Corp.	Jan. 14	CI
Newcourt Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 21	CI
Newcourt Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Newcourt Acquisition Corp announced that it expects to receive $0.75 million in funding	23-07-12	CI
Newcourt Acquisition Corp. Appoints Jurgen Van De Vyver as Chief Financial Officer	23-06-16	CI
Newcourt Acquisition Corp Announces Resignation of Daniel Rogers as Daniel Rogers	23-06-12	CI
Newcourt Acquisition Corp Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Newcourt Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Newcourt Acquisition Corp Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Newcourt Acquisition Corp Auditor Raises 'Going Concern' Doubt	23-03-22	CI
Newcourt Acquisition Corp announced that it has received $0.495 million in funding	23-01-16	CI
Refile: Psyence Details Business Combination Between Subsidiary Psyence Biomed and Nasdaq-listed Newcourt Acquisition Corp	23-01-10	MT
Psyence Details Business Combination Between Subsidiary Psyence Biomed and Nasdaq-listed Newcourt Acquisition Corp	23-01-10	MT
Newcourt Acquisition to Merge With Psyence Group's Clinical Trial Unit	23-01-10	MT
Psyence Therapeutics Corp. entered into a definitive business combination agreement to acquire Newcourt Acquisition Corp from Newcourt SPAC Sponsor LLC, Polar Asset Management Partners Inc. and others for $50 million in a reverse merger transaction.	23-01-08	CI
Newcourt Acquisition Corp announced that it expects to receive $0.495 million in funding	23-01-05	CI
Newcourt Acquisition Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Newcourt Acquisition Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI

Chart NEWT ACQU

Duration

Period

More charts

Company Profile

Newcourt Acquisition Corp. is a blank check company. The Company was formed for the purpose of effecting a merger, capital exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company has not identified any specific business combination target and has not, nor has anyone on behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company has not commenced any operations and has not commenced any revenues.

Sector

More about the company

Income Statement Evolution

More financial data